Compare RC & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RC | PALI |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.6M | 249.2M |
| IPO Year | 2011 | 2019 |
| Metric | RC | PALI |
|---|---|---|
| Price | $0.95 | $1.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $1.42 | ★ $8.90 |
| AVG Volume (30 Days) | 2.3M | ★ 3.0M |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | ★ 3.96% | N/A |
| EPS Growth | 45.25 | ★ 97.06 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $0.83 | $1.08 |
| 52 Week High | $2.80 | $2.86 |
| Indicator | RC | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 39.43 | 36.01 |
| Support Level | N/A | $1.08 |
| Resistance Level | $1.23 | $2.18 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 31.02 | 15.52 |
Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.